|
|
|
|
pmid:
|
Gewirtz AT et al. |
LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. |
1999 |
Am. J. Physiol. |
pmid:10199831
|
Levy BD et al. |
Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4. |
1999 |
FASEB J. |
pmid:10224233
|
Spokas EG et al. |
Leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids. |
1999 |
Methods Mol. Biol. |
pmid:10343320
|
Serhan CN et al. |
Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. |
1999 |
Clin. Chem. Lab. Med. |
pmid:10353476
|
Schaldach CM et al. |
Lipoxin A4: a new class of ligand for the Ah receptor. |
1999 |
Biochemistry |
pmid:10360957
|
Hachicha M et al. |
Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. |
1999 |
J. Exp. Med. |
pmid:10377187
|
Clish CB et al. |
Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10393980
|
Besse A et al. |
Prostaglandin E2 regulates macrophage colony stimulating factor secretion by human bone marrow stromal cells. |
1999 |
Biochim. Biophys. Acta |
pmid:10395955
|
Chiang N et al. |
Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. |
1999 |
J. Clin. Invest. |
pmid:10430612
|
Kikuta Y et al. |
Purification and characterization of recombinant rat hepatic CYP4F1. |
1999 |
Arch. Biochem. Biophys. |
pmid:10486137
|
Titos E et al. |
Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). |
1999 |
Am. J. Physiol. |
pmid:10564079
|
Filep JG et al. |
Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. |
1999 |
Blood |
pmid:10590058
|
Bandeira-Melo C et al. |
Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. |
2000 |
J. Immunol. |
pmid:10623853
|
Godson C et al. |
Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. |
2000 |
J. Immunol. |
pmid:10657608
|
Bandeira-Melo C et al. |
Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. |
2000 |
J. Immunol. |
pmid:10679058
|
Sodin-Semrl S et al. |
Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. |
2000 |
J. Immunol. |
pmid:10679106
|
Pouliot M and Serhan CN |
Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. |
1999 |
J. Periodont. Res. |
pmid:10685363
|
Desplat V et al. |
Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines. |
1999 |
Mediators Inflamm. |
pmid:10704149
|
Chiang N et al. |
Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. |
2000 |
J. Exp. Med. |
pmid:10748237
|